202 related articles for article (PubMed ID: 14703595)
1. Lymphocyte subpopulations in bronchopulmonary dysplasia.
Ballabh P; Simm M; Kumari J; Krauss AN; Jain A; Auld PA; Cunningham-Rundles S
Am J Perinatol; 2003 Nov; 20(8):465-75. PubMed ID: 14703595
[TBL] [Abstract][Full Text] [Related]
2. Activation of T cells in preterm infants with respiratory distress syndrome.
Turunen R; Vaarala O; Nupponen I; Kajantie E; Siitonen S; Lano A; Repo H; Andersson S
Neonatology; 2009; 96(4):248-58. PubMed ID: 19468239
[TBL] [Abstract][Full Text] [Related]
3. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil activation in preterm infants with lung disease.
Broström EB; Katz-Salamon M; Lundahl J; Halldén G; Winbladh B
Acta Paediatr; 2007 Jan; 96(1):23-8. PubMed ID: 17187598
[TBL] [Abstract][Full Text] [Related]
5. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
6. Adenosine deaminase levels in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Canpolat FE; Yurdakök M; Korkmaz A; Yiğit S; Tekinalp G
J Matern Fetal Neonatal Med; 2011 May; 24(5):703-7. PubMed ID: 20836741
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 and L-arginine in preterm infants with respiratory distress.
El Sayed M; Sherif L; Said RN; El-Wakkad AS; El-Refay A; Aly H
Am J Perinatol; 2011 Feb; 28(2):129-36. PubMed ID: 20700864
[TBL] [Abstract][Full Text] [Related]
8. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.
Groneck P; Götze-Speer B; Oppermann M; Eiffert H; Speer CP
Pediatrics; 1994 May; 93(5):712-8. PubMed ID: 8165067
[TBL] [Abstract][Full Text] [Related]
9. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia.
Bagchi A; Viscardi RM; Taciak V; Ensor JE; McCrea KA; Hasday JD
Pediatr Res; 1994 Aug; 36(2):244-52. PubMed ID: 7970941
[TBL] [Abstract][Full Text] [Related]
10. Alterations in von Willebrand factor antigen in premature infants with respiratory distress syndrome and chronic lung disease.
Patrick CH; Lazarchick J; Horn BS
Ann Clin Lab Sci; 1993; 23(1):39-46. PubMed ID: 8430999
[TBL] [Abstract][Full Text] [Related]
11. [Bronchopulmonary dysplasia--a one-year material].
Farstad T; Bratlid D
Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2524-7. PubMed ID: 2219011
[TBL] [Abstract][Full Text] [Related]
12. Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.
Ballabh P; Kumari J; Krauss AN; Shin JJ; Jain A; Auld PA; Lesser ML; Cunningham-Rundles S
Pediatrics; 2003 Mar; 111(3):461-8. PubMed ID: 12612222
[TBL] [Abstract][Full Text] [Related]
13. The association of γδ-T cells with bronchopulmonary dysplasia in premature infants.
Wang YJ; Zhang XL; Liu JX; Niu M; Jin XY; Yuan EW; Shi Y; Li WL; Xu FL
Hum Immunol; 2021 Jan; 82(1):54-59. PubMed ID: 33288226
[TBL] [Abstract][Full Text] [Related]
14. Respiratory disease and early serum S100A12 changes in very premature infants.
Loughran-Fowlds A; Leach S; Lin J; Oei J; Henry R; Day AS; Lui K
Acta Paediatr; 2011 Dec; 100(12):1538-43. PubMed ID: 21672013
[TBL] [Abstract][Full Text] [Related]
15. Incidence of bronchopulmonary dysplasia during an 11-year period in infants weighing less than 1500 g at birth.
Vanhatalo AM; Ekblad H; Kero P; Erkkola R
Ann Chir Gynaecol Suppl; 1994; 208():113-6. PubMed ID: 8092762
[TBL] [Abstract][Full Text] [Related]
16. Lower erythrocyte glutathione peroxidase activity in bronchopulmonary dysplasia in the first week of neonatal life.
Fu RH; Chiu TH; Chiang MC; Lien R; Chou YH; Chiang CC; Cho YH; Yang PH
Neonatology; 2008; 93(4):269-75. PubMed ID: 18063869
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for bronchopulmonary dysplasia in neonates with respiratory distress syndrome].
Chen Y; Han YK; Ye ZZ; Lu GJ
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):15-8. PubMed ID: 17306069
[TBL] [Abstract][Full Text] [Related]
18. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
Baier RJ; Majid A; Parupia H; Loggins J; Kruger TE
Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659
[TBL] [Abstract][Full Text] [Related]
19. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
Schmalisch G; Wauer RR; Böhme B
Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on lymphocyte subpopulations in premature infants with bronchopulmonary dysplasia.
Parimi PS; Birnkrant DJ; Rao LV; Diaz G; Moore JJ
J Perinatol; 1999; 19(5):347-51. PubMed ID: 10685255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
